1. (1) Section 58-37-101, Definitions;
2. (2) Section 58-37-102, Applicability of chapter -- Uniform construction;
3. (3) Section 58-37-104, Severability;
4. (4) Section 58-37-105, Division responsibilities -- Licensing -- Records required;
5. (5) Section 58-37-107, Controlled substances;
6. (6) Section 58-37-108, Schedules of controlled substances -- Schedules I through V -- Findings required -- Specific substances included in schedules;
7. (7) Section 58-37-109, Listed controlled substances;
8. (8) Section 58-37-110, Recognized controlled substance analogs;
9. (9) Section 58-37-111, Exceptions to applicability for certain herbs and food supplements;
10. (10) Section 58-37-114, Burden of proof in proceedings on violations;
11. (11) Section 58-37-115, Restrictions on liability for law enforcement;
12. (12) Section 58-37-202, Applicability of Title 76 to prosecutions;
13. (13) Section 58-37-203, Enforcement -- Coordination and cooperation of federal and state agencies -- Powers;
14. (14) Section 58-37-204, Investigators -- Status of peace officers;
15. (15) Section 58-37-206, Court to enjoin a violation -- Jury trial;
16. (16) Section 58-37-208, Prima facie evidence;
17. (17) Section 58-37-210, Penalties -- Bar to state prosecution;
18. (18) Section 58-37-308, Veterinary exemption for gabapentin;
19. (19) Section 58-37-403, Exemption for possession or distribution of a cannabinoid product, expanded cannabinoid product, or transportable industrial hemp concentrate;
20. (20) Section 58-37-404, Medical cannabis decriminalization; and
21. (21) Section 58-37-405, Enforcement.

Enacted by Chapter 362, 2026 General Session